Journal articles on the topic 'Brookmeyer'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 20 journal articles for your research on the topic 'Brookmeyer.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Dagenais, Marcel. "Comment on Zeger and Brookmeyer." Journal of the American Statistical Association 86, no. 413 (March 1991): 255. http://dx.doi.org/10.1080/01621459.1991.10475025.
Full textGale, Catharine R. "Dietary Antioxidants and Dementia." International Psychogeriatrics 13, no. 3 (September 2001): 259–62. http://dx.doi.org/10.1017/s1041610201007645.
Full textPencheon, D. "Monitoring the Health of Populations: Statistical Principles and Methods for Public Health Surveillance. Brookmeyer and Stroup, Oxford University Press, 2004." Journal of Public Health 27, no. 1 (March 1, 2005): 128. http://dx.doi.org/10.1093/pubmed/fdh209.
Full textBarnes, Josephine, and Nick C. Fox. "The search for early markers of AD: hippocampal atrophy and memory deficits." International Psychogeriatrics 26, no. 7 (May 30, 2014): 1065–66. http://dx.doi.org/10.1017/s1041610214000623.
Full textKudo, Masatoshi, Shukui Qin, Fabio Piscaglia, Arndt Vogel, T. R. Jeffry Evans, Jennifer J. Knox, Carlos López López, et al. "Characterization of tumor responses in patients (pts) with unresectable hepatocellular carcinoma (uHCC) treated with lenvatinib in REFLECT." Journal of Clinical Oncology 40, no. 16_suppl (June 1, 2022): 4078. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.4078.
Full textVerzoni, Elena, Alessandra Bearz, Ugo De Giorgi, Franco Nole, Camillo Porta, Raffaele Ratta, Melanie Claps, et al. "A phase II open-label study of cabozantinib in patients with advanced or unresectable renal cell carcinoma pretreated with one immune-checkpoint inhibitor: The BREAKPOINT trial." Journal of Clinical Oncology 37, no. 7_suppl (March 1, 2019): TPS685. http://dx.doi.org/10.1200/jco.2019.37.7_suppl.tps685.
Full textMolina, Ana M., Jingbo Zhang, Xun Lin, Liviu Niculescu, Beata Korytowsky, Ewa Matczak, Robin Wiltshire, and Robert John Motzer. "Sunitinib objective response (OR) in metastatic renal cell carcinoma (mRCC): Analysis of 1,059 patients treated on clinical trials." Journal of Clinical Oncology 30, no. 15_suppl (May 20, 2012): 4542. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.4542.
Full textSingh, Gunjesh Kumar, Hollis D'souza, Sujay Srinivas, Dilip Harindran Vallathol, Mounika Boppana, Annu Rajpurohit, Abhishek Mahajan, et al. "Safety and efficacy of bevacizumab biosimilar in glioma." Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020): e14541-e14541. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e14541.
Full textVon Drygalski, A., T. B. Tran, K. Messer, M. Pu, S. Corringham, C. Nelson, E. D. Ball, and E. D. Ball. "Predictors of survival in patients with metastatic breast cancer (MBC) treated with high-dose chemotherapy and autologous stem cell transplantation (HD-ASCT)." Journal of Clinical Oncology 27, no. 15_suppl (May 20, 2009): e22086-e22086. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.e22086.
Full textPuri, Akshjot, Charisma Mylavarapu, Joe E. Ensor, Parveen Parveen, Ivo Tremont-Lukats, Jenny Chee Ning Chang, and Polly Ann Niravath. "Systemic chemotherapy in patients with brain only metastatic breast cancer: A retrospective analysis." Journal of Clinical Oncology 39, no. 15_suppl (May 20, 2021): 1093. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.1093.
Full textLonardi, Sara, Marta Schirripa, Federica Buggin, Lorenzo Antonuzzo, Barbara Merelli, Giorgia Boscolo, Saverio Cinieri, et al. "First-line FOLFOX plus panitumumab versus 5FU plus panitumumab in RAS-BRAF wild-type metastatic colorectal cancer elderly patients: The PANDA study." Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020): 4002. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.4002.
Full textVan Cutsem, Eric, Iwona Danielewicz, Mark P. Saunders, Per Pfeiffer, Guillem Argiles, Christophe Borg, Robert Glynne-Jones, et al. "Phase II study evaluating trifluridine/tipiracil + bevacizumab and capecitabine + bevacizumab in first-line unresectable metastatic colorectal cancer (mCRC) patients who are noneligible for intensive therapy (TASCO1): Results of the final analysis on the overall survival." Journal of Clinical Oncology 39, no. 3_suppl (January 20, 2021): 14. http://dx.doi.org/10.1200/jco.2021.39.3_suppl.14.
Full textProcopio, Giuseppe, Melanie Claps, Chiara Pircher, Luca Porcu, Pierangela Sepe, Valentina Guadalupi, Ugo De Giorgi, et al. "A phase 2 single-arm study of cabozantinib in patients with advanced or unresectable renal cell carcinoma pretreated with one immune checkpoint inhibitor: The BREAKPOINT trial (MeetUro trial 03-NCT03463681)." Journal of Clinical Oncology 39, no. 15_suppl (May 20, 2021): 4569. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.4569.
Full textVon Drygalski, Annette, Thuy B. Tran, Karen Messer, Minya Pu, Sue Corringham, Connie Nelson, and Edward D. Ball. "Prognostic Factors for Long-Term Survival in Metastatic Breast Cancer Patients Treated with High Dose Chemotherapy and Autologous Stem Cell Transplantation." Blood 112, no. 11 (November 16, 2008): 4460. http://dx.doi.org/10.1182/blood.v112.11.4460.4460.
Full textRoschewski, Mark, Christopher Melani, Kieron Dunleavy, Matthias Holdhoff, Lode J. Swinnen, Michael Glantz, Craig A. Portell, et al. "Reponse-Adapted Study of Ibrutinib with Temozolomide, Etoposide, Doxil, Dexamethasone, and Rituximab (TEDDI-R) in Aggressive B-Cell Lymphomas with Secondary Involvement of the CNS." Blood 134, Supplement_1 (November 13, 2019): 2875. http://dx.doi.org/10.1182/blood-2019-123552.
Full textHanamoto, Hitoshi, Yasuyoshi Morita, Motoshi Ichikawa, Yasuhito Nannya, Hirohiko Shibayama, Yoshinobu Maeda, Tomoko Hata, et al. "ASXL1 Mutations Predict a Poor Response to Darbepoetin Alfa in Anemic Patients with Low-Risk MDS: A Multicenter, Phase II Study." Blood 136, Supplement 1 (November 5, 2020): 28–29. http://dx.doi.org/10.1182/blood-2020-134483.
Full textBreccia, Massimo, Michael J. Mauro, Elias Jabbour, Giuseppe Saglio, Antonio Jiménez-Velasco, Philipp D. le Coutre, Irene DeGutis, et al. "Impact of Comorbidities on Response Outcomes in Patients with Chronic Myeloid Leukemia in Chronic Phase Treated with First-Line Dasatinib Versus Imatinib: Exploratory Post Hoc Analysis of DASISION." Blood 136, Supplement 1 (November 5, 2020): 31–32. http://dx.doi.org/10.1182/blood-2020-137636.
Full textYounes, Anas, Connie Lee Batlevi, Jonathon B. Cohen, Sven de Vos, Daniel J. Landsburg, Zaw Win Myint, Krish Patel, et al. "A Multi-Center Dose-Finding Study to Assess Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Fimepinostat (CUDC-907) in Combination with Venetoclax in Patients with Relapsed/Refractory (R/R) Lymphoma." Blood 134, Supplement_1 (November 13, 2019): 4104. http://dx.doi.org/10.1182/blood-2019-128857.
Full textКапранов, Олександр. "The Framing of Dementia in Scientific Articles Published in ‘Alzheimer’s and Dementia’ in 2016." East European Journal of Psycholinguistics 3, no. 2 (December 22, 2016): 32–48. http://dx.doi.org/10.29038/eejpl.2016.3.2.kap.
Full textNaito, Toshio, Hirotake Mori, Kazutoshi Fujibayashi, Shinichi Fukushima, Mayumi Yuda, Nobuyuki Fukui, Shotaro Tsukamoto, Mai Suzuki, Keiko Goto-Hirano, and Ryohei Kuwatsuru. "Analysis of antiretroviral therapy switch rate and switching pattern for people living with HIV from a national database in Japan." Scientific Reports 12, no. 1 (February 2, 2022). http://dx.doi.org/10.1038/s41598-022-05816-5.
Full text